Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLS-005 for adult spinocerebellar ataxia type 3
CTR20230230Phase 3Suspended
- Sponsor
- Seelos Therapeutics, Inc.
- Start
- Oct 2022
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of trehalose in machado-joseph disease (MJD), sponsored by Seelos Therapeutics, Inc.. Started Oct 2022; status: suspended.
02
Drugs
trehalose
03
Conditions
machado-joseph disease (MJD)
Beyond the preview
Go deeper on CTR20230230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230230.